z-logo
open-access-imgOpen Access
Group II GBCM Can Be Used Safely for Imaging in Stage 4/5 CKD Patients: CON
Author(s) -
Patrick H. Pun,
Susan T. Crowley
Publication year - 2020
Publication title -
kidney360
Language(s) - English
Resource type - Journals
ISSN - 2641-7650
DOI - 10.34067/kid.0005572020
Subject(s) - nephrogenic systemic fibrosis , medicine , gadolinium , kidney disease , magnetic resonance imaging , disease , adverse effect , food and drug administration , radiology , pharmacology , chemistry , organic chemistry

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom